SecSonar.com

Profound Medical Corp. (PROF)

Profound Medical Corp. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Profound Medical Corp. (PROF) is a Medical - Devices company based in CA with a market capitalization of $207.1M. Revenue grew 61.1% year-over-year and free cash flow was negative at -$53.6M. This page tracks PROF's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CA · 142 employees · IPO Oct 29, 2019

Valuation

Valuation & price

$6.97 · as of May 17, 2026 · -19.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.28

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$8.65$6.30$3.96Jul 25Dec 25Jul 26Jul 7, 25$6.09Jul 9, 25$5.90Jul 11, 25$5.81Jul 15, 25$5.70Jul 17, 25$5.70Jul 21, 25$5.55Jul 23, 25$5.83Jul 25, 25$5.68Jul 29, 25$5.46Jul 31, 25$5.55Aug 4, 25$5.69Aug 6, 25$5.51Aug 11, 25$5.63Aug 13, 25$5.45Aug 15, 25$4.25Aug 19, 25$4.58Aug 21, 25$4.60Aug 25, 25$4.67Aug 27, 25$4.52Aug 29, 25$4.47Sep 3, 25$4.36Sep 5, 25$4.12Sep 9, 25$4.08Sep 11, 25$3.96Sep 16, 25$4.04Sep 18, 25$4.13Sep 22, 25$4.30Sep 24, 25$5.37Sep 26, 25$5.22Sep 30, 25$4.89Oct 2, 25$5.31Oct 6, 25$5.78Oct 8, 25$6.74Oct 10, 25$5.87Oct 14, 25$5.83Oct 16, 25$5.56Oct 21, 25$5.86Oct 23, 25$5.31Oct 27, 25$5.50Oct 29, 25$6.13Oct 31, 25$6.07Nov 4, 25$5.89Nov 6, 25$5.85Nov 10, 25$5.99Nov 12, 25$6.47Nov 14, 25$6.85Nov 18, 25$6.23Nov 20, 25$5.88Nov 25, 25$6.50Nov 28, 25$6.60Dec 2, 25$6.27Dec 4, 25$6.75Dec 8, 25$6.78Dec 10, 25$7.24Dec 12, 25$7.33Dec 16, 25$7.55Dec 18, 25$7.86Dec 22, 25$7.34Dec 24, 25$7.51Dec 29, 25$7.34Jan 2, 26$7.66Jan 6, 26$7.73Jan 8, 26$8.48Jan 12, 26$8.65Jan 14, 26$7.62Jan 16, 26$8.22Jan 21, 26$8.00Jan 23, 26$7.96Jan 27, 26$7.76Jan 29, 26$7.48Feb 2, 26$7.76Feb 4, 26$6.82Feb 9, 26$6.50Feb 11, 26$6.44Feb 13, 26$6.60Feb 18, 26$7.02Feb 20, 26$6.96Feb 24, 26$7.15Feb 26, 26$7.78Mar 2, 26$7.46Mar 4, 26$7.48Mar 6, 26$5.31Mar 10, 26$5.41Mar 12, 26$5.55Mar 17, 26$5.85Mar 19, 26$5.16Mar 23, 26$5.40Mar 25, 26$5.82Mar 27, 26$6.19Mar 31, 26$6.48Apr 2, 26$6.43Apr 7, 26$6.38Apr 9, 26$6.44Apr 13, 26$6.27Apr 15, 26$6.42Apr 17, 26$6.65Apr 22, 26$6.89Apr 24, 26$6.99Apr 28, 26$6.70Apr 30, 26$6.70May 4, 26$6.70May 6, 26$7.22May 8, 26$6.85May 12, 26$7.14May 14, 26$7.20May 18, 26$6.89May 20, 26$6.92May 22, 26$6.83May 28, 26$6.90Jun 1, 26$6.67Jun 3, 26$6.55Jun 5, 26$6.66Jun 9, 26$6.82Jun 11, 26$6.65Jun 15, 26$6.71Jun 17, 26$6.57Jun 22, 26$6.54Jun 24, 26$6.51Jun 26, 26$6.50Jul 2, 26$6.80
$3.8752-week range$8.65
Loading valuation history…

Fundamentals

Key fundamentals

$207.1M

Market cap

61.1%

Revenue growth (YoY)

70.8%

Gross margin

-$53.6M

Free cash flow (USD)

-$75.3M

Net debt

Net cash position

22.1%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$3.9MFY 2018$1.9MFY 2019$4.2MFY 2020$7.3MFY 2021$6.9MFY 2022$6.7MFY 2023$7.2MFY 2024$10.2MFY 2025$16.4M
$0$16.4M

Free cash flow by year

2016 → 2025

FY 2016$-11.6MFY 2017$-12.2MFY 2018$-13.4MFY 2019$-15.4MFY 2020$-20.9MFY 2021$-23.0MFY 2022$-25.8MFY 2023$-22.6MFY 2024$-23.5MFY 2025$-53.6M
-$11.6M-$53.6M

Gross margin by year

2021 → 2025

FY 202143.0%FY 202245.2%FY 202360.9%FY 202465.9%FY 202570.8%
43.0%70.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting NoticeMay 15, 2026Filing
  • 8-K eventPresentation AnnouncementMay 14, 2026Filing
  • FinancingSecurities RegistrationMay 12, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventEarnings Release AnnouncementApr 16, 2026Filing
  • 8-K eventInvestor Conference ParticipationApr 14, 2026Filing
  • 8-K eventPresentation AnnouncementApr 1, 2026Filing

Questions

Frequently asked questions

What is Profound Medical Corp.'s market cap?

Profound Medical Corp. (PROF) has a market capitalization of $207.1M.

What is PROF's P/E ratio?

A meaningful P/E ratio is not available for PROF — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PROF's price-to-book (P/B) ratio?

PROF trades at 2.28 times book value per share.

Are insiders buying PROF stock?

SEC Form 4 filings show no open-market insider buys at Profound Medical Corp. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

ANIK

Anika Therapeutics, Inc.

$196.4M

TMCI

Treace Medical Concepts, Inc.

$218.9M

RXST

RxSight, Inc.

$228.9M

INGN

Inogen, Inc.

$177.3M

APYX

Apyx Medical Corporation

$175.7M

EDAP

Edap Tms S.a.

$162.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.